Skip to main content
. 2019 Dec 16;11(1):98–101. doi: 10.1039/c9md00511k

Table 2. PfPKG inhibition-pyrrolidine derivatives.

Cpd % Inh@10 μM IC50 (nM) Cpd % Inh@10 μM IC50 (nM)
16a 900 16k 38
16b 360 16l 10
16c 660 16m 620
16d 13 17a 5 ND
16e 15 17b 5 ND
16f 74 17c 40 ND
16g 25 19a 2600
16h 120 19b 60 ND
16i 97 19c 46 ND
16j 47 19d 75 ND